Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer

Objective Pancreatic cancer is characterised by invasive tumour spread and early metastasis formation. During epithelial-mesenchymal transition, loss of the cell adhesion molecule E-cadherin is frequent and can be caused by genetic or epigenetic modifications, recruitment of transcriptional activato...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aghdassi, Ali (VerfasserIn) , Büchler, Markus W. (VerfasserIn)
Dokumenttyp: Article (Journal) Kapitel/Artikel
Sprache:Englisch
Veröffentlicht: 2012
In: BMJ Journals
Year: 2011, Jahrgang: 61, Heft: 3, Pages: 439-448
DOI:10.1136/gutjnl-2011-300060
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1136/gutjnl-2011-300060
Verlag, Volltext: http://gut.bmj.com/content/61/3/439
Volltext
Verfasserangaben:Ali Aghdassi, Matthias Sendler, Annett Guenther, Julia Mayerle, Claas-Olsen Behn, Claus-Dieter Heidecke, Helmut Friess, Markus Büchler, Matthias Evert, Markus M. Lerch, Frank Ulrich Weiss

MARC

LEADER 00000caa a2200000 c 4500
001 1572108231
003 DE-627
005 20220814115255.0
007 cr uuu---uuuuu
008 180418r20122011xx |||||o 00| ||eng c
024 7 |a 10.1136/gutjnl-2011-300060  |2 doi 
035 |a (DE-627)1572108231 
035 |a (DE-576)502108231 
035 |a (DE-599)BSZ502108231 
035 |a (OCoLC)1341007261 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Aghdassi, Ali  |d 1976-  |e VerfasserIn  |0 (DE-588)134184106  |0 (DE-627)56212232X  |0 (DE-576)300362595  |4 aut 
245 1 0 |a Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer  |c Ali Aghdassi, Matthias Sendler, Annett Guenther, Julia Mayerle, Claas-Olsen Behn, Claus-Dieter Heidecke, Helmut Friess, Markus Büchler, Matthias Evert, Markus M. Lerch, Frank Ulrich Weiss 
264 1 |c 2012 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online first: 5 December 2011 
500 |a Gesehen am 14.12.2018 
520 |a Objective Pancreatic cancer is characterised by invasive tumour spread and early metastasis formation. During epithelial-mesenchymal transition, loss of the cell adhesion molecule E-cadherin is frequent and can be caused by genetic or epigenetic modifications, recruitment of transcriptional activators/repressors or post-translational modifications. A study was undertaken to investigate how E-cadherin expression in human pancreatic adenocarcinoma and pancreatic cancer cell lines is regulated. Methods In 25 human pancreatic cancer resection specimens, the coding region of the E-cadherin gene (CDH1) was sequenced for somatic mutations. The tumour samples and 11 established human pancreatic cancer cell lines were analysed by immunohistochemistry, western blot analysis, chromatin immunoprecipitation and methylation-specific PCR. The role of specific histone deacetylase inhibitors (HDACi) on pancreatic tumour cell migration and proliferation was studied in vitro. Results Neither somatic mutations nor CDH1 promoter hypermethylation were found to be responsible for downregulation of E-cadherin in pancreatic cancer. In the transcriptionally active CDH1 promoter, acetylation of histones H3 and H4 was detected whereas HDAC1 and HDAC2 were found attached only to a silent promoter. Expression of ZEB1, a transcription factor known to recruit HDACs, was seen in E-cadherin-deficient cell lines in which ZEB1/HDAC complexes were found attached to the CDH1 promoter. Moreover, knockdown of ZEB1 prevented HDAC from binding to the CDH1 promoter, resulting in histone acetylation and expression of E-cadherin. HDACi treatment attenuated tumour cell migration and proliferation. Conclusions These findings imply an important role for histone deacetylation in the downregulation of E-cadherin in human pancreatic cancer. Recruitment of HDACs to the CDH1 promoter is regulated by the transcription factor ZEB1, and inhibition of HDACs may be a promising antitumour therapy for pancreatic cancer. 
534 |c 2011 
650 4 |a ACINI 
650 4 |a acute pancreatitis 
650 4 |a adhesion molecules 
650 4 |a cadherins 
650 4 |a Cancer genetics 
650 4 |a chronic pancreatitis 
650 4 |a E-cadherin 
650 4 |a epigenetics 
650 4 |a epithelial cell adhesion 
650 4 |a liver cirrhosis 
650 4 |a liver metabolism 
650 4 |a molecular oncology 
650 4 |a RNA expression 
650 4 |a trypsinogen activation peptide 
650 4 |a tumour markers 
700 1 |a Büchler, Markus W.  |d 1955-  |e VerfasserIn  |0 (DE-588)120893339  |0 (DE-627)080952526  |0 (DE-576)292434146  |4 aut 
773 0 8 |i Enthalten in  |t BMJ Journals  |d London : BMJ Publ. Group, 2008  |g 61(2012), 3, Seite 439-448  |h Online-Ressource  |w (DE-627)380721236  |w (DE-600)2138421-6  |w (DE-576)278543006  |7 nnas  |a Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer 
773 1 8 |g volume:61  |g year:2012  |g number:3  |g pages:439-448  |g extent:10  |a Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer 
856 4 0 |u http://dx.doi.org/10.1136/gutjnl-2011-300060  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://gut.bmj.com/content/61/3/439  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180418 
993 |a Article 
994 |a 2012 
998 |g 120893339  |a Büchler, Markus W.  |m 120893339:Büchler, Markus W.  |d 910000  |d 910200  |e 910000PB120893339  |e 910200PB120893339  |k 0/910000/  |k 1/910000/910200/  |p 8 
999 |a KXP-PPN1572108231  |e 3006340191 
BIB |a Y 
JSO |a {"note":["Published online first: 5 December 2011","Gesehen am 14.12.2018"],"relHost":[{"pubHistory":["1840(2008) -"],"note":["Gesehen am 16.04.2021"],"titleAlt":[{"title":"BMJ Journals Standard Collection"},{"title":"BMJ Journals Publish & Read"},{"title":"BMJ journals online collection"},{"title":"BMJ Journals [Komplett]"}],"part":{"text":"61(2012), 3, Seite 439-448","extent":"10","volume":"61","pages":"439-448","issue":"3","year":"2012"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"corporate":[{"display":"BMJ Publishing Group","role":"isb"}],"type":{"bibl":"edited-book","media":"Online-Ressource"},"title":[{"title_sort":"BMJ Journals","title":"BMJ Journals"}],"disp":"Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancerBMJ Journals","recId":"380721236","origin":[{"dateIssuedKey":"2008","publisher":"BMJ Publ. Group","dateIssuedDisp":"2008-","publisherPlace":"London"}],"id":{"zdb":["2138421-6"],"eki":["380721236"]}}],"physDesc":[{"extent":"10 S."}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"chapter"},"title":[{"title_sort":"Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer","title":"Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer"}],"person":[{"display":"Aghdassi, Ali","family":"Aghdassi","role":"aut","given":"Ali"},{"display":"Büchler, Markus W.","family":"Büchler","role":"aut","given":"Markus W."}],"recId":"1572108231","name":{"displayForm":["Ali Aghdassi, Matthias Sendler, Annett Guenther, Julia Mayerle, Claas-Olsen Behn, Claus-Dieter Heidecke, Helmut Friess, Markus Büchler, Matthias Evert, Markus M. Lerch, Frank Ulrich Weiss"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012"}],"id":{"doi":["10.1136/gutjnl-2011-300060"],"eki":["1572108231"]}} 
SRT |a AGHDASSIALRECRUITMEN2012